argenx SE (LON:0QW0)
London · Delayed Price · Currency is GBP · Price in EUR 695.94
-7.70 (-1.09%)
At close: Jan 9, 2026
argenx SE Market Cap
argenx SE has a market cap or net worth of 36.83 billion as of January 9, 2026. Its market cap has increased by 22.96% in one year.
Market Cap
36.83B
Enterprise Value
33.96B
Revenue
2.74B
Ranking
n/a
PE Ratio
32.29
Stock Price
695.94
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 97.26M to 36.83B, an increase of 37,768.29%. That is a compound annual growth rate of 67.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 36.83B | -3.76% |
| Dec 31, 2025 | 38.27B | 27.76% |
| Dec 31, 2024 | 29.95B | 70.09% |
| Dec 29, 2023 | 17.61B | 3.04% |
| Dec 30, 2022 | 17.09B | 24.91% |
| Dec 31, 2021 | 13.68B | 33.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.60B |
| GSK plc | 76.29B |
| Haleon | 33.27B |
| Smith & Nephew | 10.66B |
| Convatec Group | 4.75B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.72B |